[31] demonstrated that the elevation of cellular PpIX using celecoxib is related to a down regulation of Akt/NF-kB/MDR1 pathway, thus enhancing the anti-tumor efficacy of SDT. This evidence concerns the gene ABCB1 and neoplasm.